Article Information
History
- December 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alexandra Tauzin1,2,
- Mehdi Benlarbi1,2,
- Halima Medjahed1,
- Yves Grégoire3,
- Josée Perreault3,
- Gabrielle Gendron-Lepage1,
- Laurie Gokool1,
- Chantal Morisseau1,
- Pascale Arlotto1,
- Cécile Tremblay1,
- Daniel E. Kaufmann1,4,5,
- Valérie-Martel-Laferrière1,2,
- Inès Levade6,
- Marceline Côté7,
- Gaston de Serres8,
- Renée Bazin3 and
- Andrés Finzi1,2,#
- 1Centre de Recherche du CHUM, Montreal, QC, Canada
- 2Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada
- 3Héma-Québec, Affaires Médicales et Innovation, Quebec, QC, Canada
- 4Département de Médecine, Université de Montréal, Montreal, QC, Canada
- 5Division of Infectious Diseases, Department of Medicine, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland
- 6Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne de- Bellevue, QC, Canada
- 7Department of Biochemistry, Microbiology and Immunology, and Centre for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON, Canada
- 8Institut National de Santé Publique du Québec, Quebec, QC, Canada
- ↵#Correspondance: Andrés Finzi, andres.finzi{at}umontreal.ca
Posted December 20, 2022.
Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
